A Shot In The Arm For Cancer Patients?Kate Murphy
When Ernest Graf, retired president of Ben Kahn Furs in New York, was diagnosed with prostate cancer in 1993, he underwent radiation treatment. Then he opted to receive an experimental vaccine developed by Memorial Sloane-Kettering Cancer Center in New York. "I didn't want the side effects" associated with hormonal therapy, such as lethargy and diminished libido, says Graf, 79, who received four shots over 18 months. With his cancer now in remission, he credits his good health to the vaccine and to an active lifestyle that includes biking and skiing: "It strengthened my immune system without slowing me down," he says.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Fewest Jobless Claims Since 1973 Show Firm U.S. Job Market
- Greenwich Mansion Listings Pulled to Wait for a Better Day
- U.S. Stocks Climb With Treasuries as Dollar Slides: Markets Wrap
- The U.K.'s $86 Billion Pension Problem Is About to Solve Itself
- Germans Are Going Wild for a Show Set During the Dawn of the Nazis